Waiver of protocol approval by phase for drugs, etc. eyed

Published: 2002-03-05 07:00:00

Updated: 2002-03-05 07:00:00

The approval of protocol by phase of drugs etc. is to be waived by the Korea Food and Drug Administration (KFDA), in order to introduce a prior consultation system and facilitate the R&D projects. Instead,, the KFDA says that the prior consultation system of drugs, etc. will be fully implemented next year through the preliminary enlightenment period in this year.

Under the new system, the cl...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.